Drug Topics November 13, 2024
Brian Nowosielski

An FDA representative gave a presentation on her organization’s recent updates regarding drug supply chain rules and regulations.

In order to maintain the integrity of the US drug supply chain, it’s the shared goal of pharmacists, manufacturers, and regulators to focus on protecting all pharmaceutical products, and ultimately the patient receiving those products, from harm. From enforcement actions and warning letters to new programs furthering the organization’s mission, the FDA is working around the clock with several supply chain contributors to ensure safety and security within US pharmacies.

“We need to make sure that our federal requirements, layered with our state requirements, maintain the integrity of the pharmaceutical supply chain to protect the product and ultimately protect the patient. That’s...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Conferences / Podcast, FDA, Govt Agencies, Pharma, Pharma / Biotech, Trends
FDA warns GLP-1 compounder over safety rules
GLP-1 drug approvals: A breakdown
Rethinking FDA’s Accelerated Approval Pathway: New Draft Guidances and Implications for Drug Companies
FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use
Certainty vs. speed: How do patients feel about the tradeoff for new cancer drugs?

Share This Article